Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Complix NV (protein therapeutics for cancer and autoimmune diseases) raised €12mm ($15.5mm) through its Series B round co-led by new investors Edmond de Rothschild Investment Partners, GIMV, and Biotech Fund Flanders (managed by GIMV). LRM, Omnes Capital, Vesalius Biocapital, Gemma Frisius Fund, TrustCapital, Vinnof, Baekeland Fund, CRP-Santé, and members of Complix’s management also participated. One executive from Edmond de Rothschild and GIMV will join the company's board.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?